Corporate governance

Corporate governance at Nobel Biocare follows the Swiss Code of Best Practice for Corporate Governance (SCBP).

Nobel Biocare Holding AG (the Company) is a limited liability company incorporated and domiciled in Switzerland, where it is listed on the SIX Swiss Exchange. Corporate Governance at Nobel Biocare follows the “Swiss Code of Best Practice for Corporate Governance” (economiesuisse, revised version 2008).

The company's Corporate Governance report follows the SIX Swiss Exchange Directive on Information Relating to Corporate Governance (DCG, SIX Swiss Exchange Corporate Governance Directive, revised version 2008).

As a publicly-listed company and for the benefit of all relevant stakeholders, including the financial markets, customers, employees and the general public, Nobel Biocare pursues an open and active information policy.

Nobel Biocare publishes the Group’s financial accounts, together with interim reports, every quarter. These reports are published in English. The consolidated financial statements are prepared in accordance with International Financial Reporting Standards (IFRSs) and comply with Swiss law.

• 

  Managing and supervisory boards

  Meet the members of the Board of Directors and the Executive Committee and learn more about their responsibilities, such as membership and attendance in meetings of the Board Committees.

• 

  Policies and guidelines

  Nobel Biocare is strongly committed to maintaining high standards of business ethics. This section provides an overview of the company's corporate principles such as the Nobel Biocare Code of Conduct and other guidelines and policies.

• 

  Remuneration report

  Nobel Biocare's remuneration report is intended to provide an overview of Nobel Biocare’s compensation principles. It includes compensation disclosures of the Executive Committee and Board of Directors.